EHR

Precise Introduces the First Unified Behavioral Health Operating System BOS Servicing the Complete Care Continuum

Designed by clinicians for clinicians, BOS improves clinical outcomes, financial performance, and value-based care results. LOS ANGELES, CA / ACCESS...

VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge

SAN JOSE, CALIFORNIA / ACCESS Newswire / November 11, 2025 / VSee Health, Inc. (Nasdaq:VSEE) a leader in HIPAA-compliant telemedicine...

Pharmacovigilance Market to Reach $26.2 billion, Globally, by 2034 at 12.3% CAGR: Allied Market Research

Pharmacovigilance is increasingly adopted across pharmaceutical companies, regulatory bodies, clinical research organizations, and healthcare providers due to its critical role...

Encouraging Results from a First-in-Human Phase 1 Clinical Trial of IAVI’s Lassa Vaccine Candidate Published in New England Journal of Medicine

One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways:IAVI's Lassa vaccine candidate...

Encouraging Results from a First-in-Human Phase 1 Clinical Trial of IAVI’s Lassa Vaccine Candidate Published in New England Journal of Medicine

One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways:IAVI's Lassa vaccine candidate...

error: Content is protected !!